Get started
Author

Kirk E. Evoy

Abuse and Misuse of Pregabalin and Gabapentin
2017 · Kirk E. Evoy, Megan D. Morrison, et al. · Drugs · 410
Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update
2020 · Kirk E. Evoy, Sarvnaz Sadrameli, et al. · Drugs · 240
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
2018 · Alyssa M Peckham, Kirk E Evoy, et al. · Substance Abuse Research and Treatment · 108
PDF
Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS)
2018 · Kirk E. Evoy, Jordan R. Covvey, et al. · Research in Social and Administrative Pharmacy · 104
Suvorexant
2015 · Kunal V. Patel, Anthony V. Aspesi, et al. · Annals of Pharmacotherapy · 72
Prevalence and characteristics of self-reported kratom use in a representative US general population sample
2020 · Jordan R. Covvey, Samantha M. Vogel, et al. · Journal of Addictive Diseases · 69
Naloxone Accessibility Without a Prescriber Encounter Under Standing Orders at Community Pharmacy Chains in Texas
2018 · Kirk E. Evoy, Lucas G. Hill, et al. · JAMA · 65
PDF
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA
2020 · Lucas G. Hill, Lindsey J. Loera, et al. · Addiction · 61
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states
2022 · Lucas G. Hill, Lindsey J. Loera, et al. · Drug and Alcohol Dependence · 57
Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability
2021 · Kirk E. Evoy, Alyssa M. Peckham, et al. · The Journal of Clinical Pharmacology · 49
PDF
Impact of student pharmacist–led naloxone academic detailing at community pharmacies in Texas
2019 · Kirk E. Evoy, Lindsey Groff, et al. · Journal of the American Pharmacists Association · 45
Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population
2018 · Alyssa M. Peckham, Kirk E. Evoy, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 44
Combination bupropion SR and varenicline for smoking cessation: a systematic review
2016 · Tiffany Vogeler, Claire McClain, et al. · The American Journal of Drug and Alcohol Abuse · 44
Considering the Potential Benefits of Over-the-Counter Naloxone
2021 · Kirk E Evoy, Lucas G Hill, et al. · Integrated Pharmacy Research and Practice · 43
PDF
Pimavanserin: A Novel Drug Approved to Treat Parkinson's Disease Psychosis.
2018 · Amanda K Kitten, Sarah A Hallowell, et al. · PubMed · 39
Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample
2021 · Kirk E. Evoy, Jordan R. Covvey, et al. · International Journal of Clinical Pharmacy · 35
Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics
2019 · Kirk E Evoy, Chengwen Teng, et al. · Substance Abuse Research and Treatment · 32
Naloxone accessibility without an outside prescription from U.S. community pharmacies: A systematic review
2022 · Rachael K. Lai, Kelsie Ellis Friedson, et al. · Journal of the American Pharmacists Association · 31
Pharmacist counseling when dispensing naloxone by standing order: A secret shopper study of 4 chain pharmacies
2020 · Jillian Contreras, Courtney Baus, et al. · Journal of the American Pharmacists Association · 25
Stop the Bleed: An Interprofessional Community Service Learning Project Assessing the Efficacy of Pharmacist-Led Hemorrhage Control Education for Laypersons
2020 · Robert Moton, Courtney Baus, et al. · Disaster Medicine and Public Health Preparedness · 23
Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction
2019 · Lucas G. Hill, Kirk E. Evoy, et al. · Journal of the American Pharmacists Association · 19
Kratom as a potential substance use disorder harm reduction agent
2024 · MeShell Green, Nina Vadiei, et al. · Frontiers in Public Health · 17
Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients
2021 · Elizabeth A. Ibiloye, Jamie C. Barner, et al. · Clinical Drug Investigation · 17
Aflibercept: Newly Approved for the Treatment of Macular Edema Following Central Retinal Vein Occlusion
2013 · Kirk E Evoy, Steven R Abel · Annals of Pharmacotherapy · 17
Early Use of Ceftaroline Fosamil in the United States Veterans Health Care System
2017 · Rachel S. Britt, Kirk E. Evoy, et al. · Drugs · 13
Works count: 79
Citation count: 1,828
H-index: 20
I10-index: 29
Year
Topic
Type